findmyKOL
Clinical trialNCT01690390UnknownPhase 2Interventional

Dose Escalation of Icotinib in Advanced Non-small Cell Lung Carcinoma (NSCLC) Patients Evaluated as Stable Disease

SponsorBetta Pharmaceuticals Co., Ltd.Enrollment180NSCLC
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Fujian Hospital for Chest Tumors & Tuberculosis Diseases

    Fuzhou, Fujian, China

    Chen Qun, M.D.
    Recruiting
  • Fujian Provincal Cancer Hospital

    Fuzhou, Fujian, China

    Huang Cheng, M.D.
    Recruiting
  • Fujian Provincal Hospital

    Fuzhou, Fujian, China

    Cui Tongjian, M.D.
    Recruiting
  • the Second Hospital of Xiamen City

    Xiamen, Fujian, China

    Ke Mingyao, M.D.
    Recruiting
  • Hunan Provincal Cancer Hospital

    Changsha, Hunan, China

    Wu Lin, M.D.
    Recruiting
  • the Second People'S Hospital of Sichuan

    Chengdu, Sichuan, China

    Yu Jingrui, M.D.
    Recruiting
  • Sir Run Run Shaw Hospital

    Hangzhou, Zhejiang, China

    Pan Minghong, M.D.
    Recruiting
  • the First Affiliated Hospital of Medical School of Zhejiang University

    Hangzhou, Zhejiang, China

    Zhou Jianying, M.D.
    Recruiting
  • the Second Affiliated Hospital of Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

    Huang Jianjin, M.D.
    Recruiting
  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, China

    Zhang Yi Ping, M.D.
    Recruiting
  • Zhejiang Hospital

    Hangzhou, Zhejiang, China

    Active, not recruiting
  • Zhejiang Provincial People'S Hospital

    Hangzhou, Zhejiang, China

    Lu Li Qin, M.D.
    Recruiting
  • Zhejiang Traditional Chinese Medical Hospital

    Hangzhou, Zhejiang, China

    Active, not recruiting
  • Ningbo Medical Treatment Center Lihuili Hospital

    Ningbo, Zhejiang, China

    Shen Weiyu, M.D.
    Recruiting
  • Yinzhou People'S Hospital

    Ningbo, Zhejiang, China

    Guo Jianxin, M.D.
    Recruiting
  • Taizhou Hospital of Zhejiang Province

    Taizhou, Zhejiang, China

    Hu Wei, M.D.
    Recruiting
  • the First Affiliated Hospital of Wenzhou Medical College

    Wenzhou, Zhejiang, China

    Li Wenfeng, M.D.
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2012
Primary completion
31 Dec 2015
Completion
31 Jul 2016
Last update posted
30 Dec 2014
Registered enrollment
180
Registry id
NCT01690390

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.